Molecular Detection Technologies for Helicobacter pylori Antibiotic Resistance: Current Status and Clinical Implications
Zhenyu Wang, Jun Lin, Xuanni Zhang, Juan Yang, Yao Liu, Yuan Ji · 2026
Read Molecular Detection Technologies for Helicobacter pylori Antibiotic Resistance: Current Status and Clinical Implications by Zhenyu Wang, Jun Lin, Xuanni Zhang, Juan Yang, Yao Liu, Yuan Ji (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13680304.txt.
Description
Zhenyu Wang and five co-authors review fast genetic tests for drug resistance in the stomach bacterium Helicobacter pylori, in a 2026 paper. The bacterium infects about half of humanity and drives gastritis, ulcers, and stomach cancer. Resistance to the antibiotics used against it is rising and varies sharply by region, undermining standard treatment.
Resistance mostly comes from mutations in target genes, pumps that expel drugs, and changed membrane permeability. Molecular tests spot the mutations directly and beat slow culture methods on speed and precision, though they cost more and still need invasive samples. Treatment has shifted toward four-drug mixes containing bismuth and newer acid blockers. The authors look ahead to cheaper multi-target test platforms, resistance tracking networks, and prediction models, urging a move from guess-based prescribing to precision treatment.
Catalog record
| CREATOR | Zhenyu Wang, Jun Lin, Xuanni Zhang, Juan Yang, Yao Liu, Yuan Ji |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |